Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial

By Beasley C.M.   Hamilton S.H.   Crawford A.M.   Dellva M.A.   Tollefson G.D.   Tran P.V.   Blin O.   Beuzen J.-N.  

European Neuropsychopharmacology, Vol. 7, Iss. 2, 1997-05 ,pp. : 125-137

Elsevier

Access to resources Recommend Favorite

Nizatidine for prevention of weight gain with olanzapine: a double-blind placebo-controlled trial

By Cavazzoni P.   Tanaka Y.   Roychowdhury S.M.   Breier A.   Allison D.B.  

European Neuropsychopharmacology, Vol. 13, Iss. 2, 2003-03 ,pp. : 81-85

Elsevier

Access to resources Recommend Favorite

Nicergoline in the long term treatment of mild or moderate senile dementia. A multicenter double-blind, randomized, placebo-controlled trial

By Nicergoline Dementia Long Term Study Italian Group   Battaglia A.   Annoni K.   Pamparana F.   De Paolis C.   Bonura M.L.   Stekke W.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 383-383

Elsevier

Access to resources Recommend Favorite

Long-term Effect of Glimepiride and Rosiglitazone on Non-conventional Cardiovascular Risk Factors in Metformin-treated Patients Affected by Metabolic Syndrome: a Randomized, Double-blind Clinical Trial

By Derosa G   Gaddi AV   Ciccarelli L   Fogari E   Ghelfi M   Cicero AFG  

The Journal of International Medical Research, Vol. 33, Iss. 3, 2005-05 ,pp. : 284-294

Field House Publishing

Access to resources Recommend Favorite

Acetyl-L-Carnitine (Levacecarnine) in the Treatment of Diabetic Neuropathy: A Long-Term, Randomised, Double-Blind, Placebo-Controlled Study

By De Grandis D.  

Drugs in R&D, Vol. 3, Iss. 4, 2002-01 ,pp. : 223-231

Adis International

Access to resources Recommend Favorite